Pacira BioSciences, Inc.PCRXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+13.2%
5Y CAGR+13.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+13.2%/yr
vs +9.5%/yr prior
5Y CAGR
+13.8%/yr
Consistent
Acceleration
+3.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $368.76M | +25.4% |
| 2024 | $294.10M | +9.2% |
| 2023 | $269.44M | +5.9% |
| 2022 | $254.52M | +27.7% |
| 2021 | $199.34M | +3.0% |
| 2020 | $193.52M | -3.6% |
| 2019 | $200.78M | +13.3% |
| 2018 | $177.26M | +9.8% |
| 2017 | $161.49M | +5.8% |
| 2016 | $152.61M | - |